Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complete Response to Full-Dose Sorafenib Treatment in an Elderly HCC Patient: a Case Report.

Literature DB >> 25894635

Complete Response to Full-Dose Sorafenib Treatment in an Elderly HCC Patient: a Case Report.

G de Stefano¹, V Iodice², N Farella².

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2015 PMID： 25894635 DOI： 10.1007/s12029-015-9720-5

Source DB: PubMed Journal: J Gastrointest Cancer

Keyword Cloud
References

× No keyword cloud information.

17 in total

1. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

Authors: Jordi Bruix; Jean-Luc Raoul; Morris Sherman; Vincenzo Mazzaferro; Luigi Bolondi; Antonio Craxi; Peter R Galle; Armando Santoro; Michel Beaugrand; Angelo Sangiovanni; Camillo Porta; Guido Gerken; Jorge A Marrero; Andrea Nadel; Michael Shan; Marius Moscovici; Dimitris Voliotis; Josep M Llovet
Journal: J Hepatol Date: 2012-06-19 Impact factor: 25.083

2. Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy.

Authors: Bassam Estfan; Michael Byrne; Richard Kim
Journal: Am J Clin Oncol Date: 2013-08 Impact factor: 2.339

3. Sorafenib in elderly patients with advanced hepatocellular carcinoma: a case series.

Authors: Liliana Montella; Raffaele Addeo; Gregorio Cennamo; Bruno Vincenzi; Rita Palmieri; Pasquale Sperlongano; Rossella Sperlongano; Patrizia Iodice; Paola Russo; Salvatore Del Prete
Journal: Oncology Date: 2013-02-20 Impact factor: 2.935

4. Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib.

Authors: Bruno Vincenzi; Daniele Santini; Antonio Russo; Raffaele Addeo; Francesco Giuliani; Liliana Montella; Sergio Rizzo; Olga Venditti; Anna Maria Frezza; Michele Caraglia; Giuseppe Colucci; Salvatore Del Prete; Giuseppe Tonini
Journal: Oncologist Date: 2010-01-05

5. Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib.

Authors: Andrea L Inghilesi; Donatella Gallori; Lorenzo Antonuzzo; Paolo Forte; Daniela Tomcikova; Umberto Arena; Stefano Colagrande; Silvia Pradella; Bernardo Fani; Elena Gianni; Luca Boni; Giacomo Laffi; Francesco Di Costanzo; Fabio Marra
Journal: World J Gastroenterol Date: 2014-01-21 Impact factor: 5.742

6. Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial.

Authors: Ann-Lii Cheng; Yoon-Koo Kang; Deng-Yn Lin; Joong-Won Park; Masatoshi Kudo; Shukui Qin; Hyun-Cheol Chung; Xiangqun Song; Jianming Xu; Guido Poggi; Masao Omata; Susan Pitman Lowenthal; Silvana Lanzalone; Liqiang Yang; Maria Jose Lechuga; Eric Raymond
Journal: J Clin Oncol Date: 2013-09-30 Impact factor: 44.544

7. Impact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinoma.

Authors: Giovan Giuseppe Di Costanzo; Raffaella Tortora; Massimo De Luca; Alfonso Galeota Lanza; Filippo Lampasi; Maria Teresa Tartaglione; Francesco Paolo Picciotto; Michele Imparato; Silvana Mattera; Gabriella Cordone; Antonio Ascione
Journal: Med Oncol Date: 2013-01-10 Impact factor: 3.064